MAP7D1-EIF2C3 Fusion FISH Probe
The MAP7D1-EIF2C3 Fusion FISH Probe is used to confirm a fusion of the MAP7D1 and EIF2C3 genes. The fusion of the MAP7D1 and EIF2C3 genes has been associated with Uterine Corpus Endometrial Carcinoma. These probes are FISH confirmed on normal peripheral blood in both interphase nuclei and metaphase spreads before shipment. Typical turnaround time for this product is 7-14 days after purchase.
** This product is for in vitro and research use only. This product is not intended for diagnostic use. Please note that both genes fall on the same chromosome and inter-chromosomal detection may be difficult to detect depending on the genes proximity to one another. Please consult our support staff before ordering this product to ensure that the probe can be designed to meet your specific needs.
| SKU | Test Kits | Buffer | Dye Color | Order Now |
|---|---|---|---|---|
| MAP7D1-EIF2C3-20-ORGR (Standard Design) | 20 (40 μL) | 200 μL |
|
|
| MAP7D1-EIF2C3-20-RERE | 20 (40 μL) | 200 μL |
|
|
| MAP7D1-EIF2C3-20-REOR | 20 (40 μL) | 200 μL |
|
|
| MAP7D1-EIF2C3-20-REGO | 20 (40 μL) | 200 μL |
|
|
| MAP7D1-EIF2C3-20-REGR | 20 (40 μL) | 200 μL |
|
|
| MAP7D1-EIF2C3-20-REAQ | 20 (40 μL) | 200 μL |
|
|
| MAP7D1-EIF2C3-20-ORRE | 20 (40 μL) | 200 μL |
|
|
| MAP7D1-EIF2C3-20-OROR | 20 (40 μL) | 200 μL |
|
|
| MAP7D1-EIF2C3-20-ORGO | 20 (40 μL) | 200 μL |
|
|
| MAP7D1-EIF2C3-20-ORAQ | 20 (40 μL) | 200 μL |
|
|
| MAP7D1-EIF2C3-20-GORE | 20 (40 μL) | 200 μL |
|
|
| MAP7D1-EIF2C3-20-GOOR | 20 (40 μL) | 200 μL |
|
|
| MAP7D1-EIF2C3-20-GOGO | 20 (40 μL) | 200 μL |
|
|
| MAP7D1-EIF2C3-20-GOGR | 20 (40 μL) | 200 μL |
|
|
| MAP7D1-EIF2C3-20-GOAQ | 20 (40 μL) | 200 μL |
|
|
| MAP7D1-EIF2C3-20-GRRE | 20 (40 μL) | 200 μL |
|
|
| MAP7D1-EIF2C3-20-GROR | 20 (40 μL) | 200 μL |
|
|
| MAP7D1-EIF2C3-20-GRGO | 20 (40 μL) | 200 μL |
|
|
| MAP7D1-EIF2C3-20-GRGR | 20 (40 μL) | 200 μL |
|
|
| MAP7D1-EIF2C3-20-GRAQ | 20 (40 μL) | 200 μL |
|
|
| MAP7D1-EIF2C3-20-AQRE | 20 (40 μL) | 200 μL |
|
|
| MAP7D1-EIF2C3-20-AQOR | 20 (40 μL) | 200 μL |
|
|
| MAP7D1-EIF2C3-20-AQGO | 20 (40 μL) | 200 μL |
|
|
| MAP7D1-EIF2C3-20-AQGR | 20 (40 μL) | 200 μL |
|
|
| MAP7D1-EIF2C3-20-AQAQ | 20 (40 μL) | 200 μL |
|
MAP7D1 Gene Summary
The MAP7 Domain Containing 1 (MAP7D1) gene is located on chr1 :36621802-36646441 at 1p34.3.
Gene Name: MAP7 Domain Containing 1
Chromosome: CHR1: 36621802 -36646441
Locus: 1p34.3
Gene Diseases
The MAP7D1 EIF2C3 Fusion has been associated with the following diseases:
| Disease Name |
|---|
| Uterine Corpus Endometrial Carcinoma |
FISH Probe Protocols
| Protocol, Procedure, or Form Name | Last Modified | Download |
|---|